Funds holding AEON BIOPHARMA INC
ISIN US00791X2099 · United States
- Fund holders
- 4
- Of which ETFs
- 0 4 other funds
- Value held
- 111.9K $
- Share of capital
- 0.3 % of 49.9M shares on Aug 6, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 90,529 | 65.1K $ | 0.00 % | 0.18 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 47,535 | 36K $ | 0.00 % | 0.10 % | as of May 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 11,192 | 8.5K $ | 0.02 % | as of May 31, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 3,072 | 2.3K $ | 0.01 % | as of May 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 4 | 0 | 152,328 | +4.5 % |
| 2026Q2 | 4 | 0 | 145,792 | +17.6 % |
| 2026Q1 | 4 | 0 | 123,996 | +1.9 % |
| 2025Q4 | 4 | 0 | 121,702 | +434.8 % |
| 2025Q3 | 4 | -2 | 22,758 | +172.7 % |
| 2025Q2 | 6 | 8,345 |
Institutional managers
21 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| Dauntless Investment Group, LLC | 2,527,775 | 2.5M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 87,062 | 85.8K $ | as of Mar 31, 2026 |
| Blue Owl Capital Holdings LP | 42,353 | 41.5K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 20,424 | 20.1K $ | as of Mar 31, 2026 |
| Formidable Asset Management, LLC | 20,024 | 22K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 16,376 | 16.1K $ | as of Mar 31, 2026 |
| LPL Financial LLC | 11,507 | 11.3K $ | as of Mar 31, 2026 |
| UBS Group AG | 4,182 | 4.1K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 2,834 | 2.8K $ | as of Mar 31, 2026 |
| Steward Partners Investment Advisory, LLC | 1,100 | 1.1K $ | as of Mar 31, 2026 |
| CITIGROUP INC | 742 | 731 $ | as of Mar 31, 2026 |
| WOLFF WIESE MAGANA LLC | 567 | 559 $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 470 | 463 $ | as of Mar 31, 2026 |
| DUPONT CAPITAL MANAGEMENT CORP | 170 | 167 $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 150 | 148 $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 105 | 103 $ | as of Mar 31, 2026 |
| GHP Investment Advisors, Inc. | 95 | 94 $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 90 | 89 $ | as of Mar 31, 2026 |
| MAI Capital Management | 58 | 58 $ | as of Mar 31, 2026 |
| DANSKE BANK A/S | 1 | 1 $ | as of Mar 31, 2026 |
| Caitong International Asset Management Co., Ltd | 1 | 1 $ | as of Mar 31, 2026 |
Declared shareholders of AEON BIOPHARMA INC
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Timothy P. Lynch | 13.00 % | 6,500,000 | as of Aug 19, 2026 · SCHEDULE 13G |
| Stonepine Capital Management, LLC and 3 others | 9.90 % | 6,892,682 | as of Jul 15, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding AEON BIOPHARMA INC". https://titelia.com/en/stocks/aeon-biopharma-inc-US00791X2099